Reduce red tape, delays at FDA | Advertiser-Tribune One of the villains in last year's scandal over EpiPens sold by Mylan Pharmaceuticals was the U.S. Food and Drug Administration, as we pointed out. That agency is about to get a new director. Public outrage focused on Mylan for its pricing of the EpiPen, a device used to inject a drug that counteracts severe […]

Your session was unable to be renewed and will be expiring in 0 seconds. Click here to attempt to renew your session.
Michael R. Webb
Sign up now for our free newsletters! Today's breaking news and more in your inbox Sign up Now!
Community Calendar, March 16
Back
Loading...
View Page in Progress

Reduce red tape, delays at FDA